| Dr Shirley Eyman, MD | |
|
1450 E 10th St, Rolla, MO 65401-3648 | |
| (573) 364-7551 | |
| (573) 364-4898 |
| Full Name | Dr Shirley Eyman |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1450 E 10th St, Rolla, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871773986 | NPI | - | NPPES |
| 205785918 | Medicaid | MO | |
| 57050080 | Other | MO | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 200102473 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shirley Eyman, MD 1450 E 10th St, Rolla, MO 65401-3648 Ph: (573) 364-7551 | Dr Shirley Eyman, MD 1450 E 10th St, Rolla, MO 65401-3648 Ph: (573) 364-7551 |
News Archive
Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
In a continuing effort to educate prescribers and patients about the potential risks related to opioid use, the U.S. Food and Drug Administration today announced required class-wide safety labeling changes for immediate-release (IR) opioid pain medications. Among the changes, the FDA is requiring a new boxed warning about the serious risks of misuse, abuse, addiction, overdose and death.
Helicos BioSciences Corporation provided updates on recent scientific findings and progress on Helicos's technology initiatives. Speaking at the Personal Genomes conference in Cold Spring Harbor, NY, and the CHI Next Generation Sequencing conference in Providence, RI, Patrice Milos, Ph.D. Vice President and Chief Scientific Officer provided an overview of recent technological and scientific initiatives underway at Helicos.
Molecular Detection Inc. a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced that its Detect-Ready MRSA assay has received its first independent validation in a study conducted at St. George's Healthcare NHS Trust, a leading teaching hospital in the UK.
› Verified 4 days ago
Mignon M Makos, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-9000 Fax: 816-364-3894 | |
Dr. Sreekant Kodela, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1450 E 10th St, Rolla, MO 65401 Phone: 888-403-1071 | |
Dr. Lirong Zhu, M.D., PH.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1605 Martin Springs Dr, Suite 360b, Rolla, MO 65401 Phone: 573-458-6380 Fax: 573-458-6464 | |
Dr. Shannon Liane Robinson, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1000 W 10th St, Rolla, MO 65401 Phone: 573-364-9000 Fax: 573-202-2484 | |
Dr. Michelle M Hill, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 575b Blues Lake Pkwy, Rolla, MO 65401 Phone: 573-364-2007 Fax: 573-202-2455 | |
Dr. Sasan Moshirzadeh, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1050 W 10th St, Rolla, MO 65401 Phone: 573-364-9000 Fax: 573-202-2484 | |
Madeleine A Philpot, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 575 Blues Lake Parkway, Pcrmc Center Clinic, Rolla, MO 65401 Phone: 573-426-2214 Fax: 573-202-2455 |